3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Carcinoma, Hepatocellular
36
Cholangiocarcinoma
11
Carcinoma, Renal Cell
10
Stomach Neoplasms
5
Liver Neoplasms
5
Neoplasms
4
Endometrial Neoplasms
4
Biliary Tract Neoplasms
4
Uterine Cervical Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Vulvar Neoplasms
2
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Recurrence
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Liver Diseases
2
Kidney Neoplasms
2
Cirrhosis, Familial, with Pulmonary Hypertension
2
Breast Neoplasms
2
Advanced Solid Tumor
2
von Hippel-Lindau Disease
1
Urogenital Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thymoma
1
Solid Tumor, Adult
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Penile Neoplasms
1
Interventions
Pemetrexed
4
Cisplatin
4
pembrolizumab
3
Nivolumab
3
Interleukin-2
3
Carboplatin
3
atezolizumab
2
aldesleukin
2
Pharmaceutical Preparations
2
Ipilimumab
2
olaparib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
Thoracoscopy
1
Thoracic Surgery, Video-Assisted
1
Surgery, Computer-Assisted
1
Proton Therapy
1
Platinum
1
Paclitaxel
1
Injections
1
Influenza Vaccines
1
Indocyanine Green
1
In Situ Hybridization, Fluorescence
1
Cyclophosphamide
1
Combined Modality Therapy
1
Cerebral Decortication
1
Brentuximab Vedotin
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Mesothelioma, Malignant
×
lenvatinib
×
Clear all
NCT06318286
2025-05-25
PENINSULA
Hyogo Medical University
Phase 2
Recruiting
25 enrolled